BCL2A1 and ovarian serous adenocarcinoma: To investigate the relationship between BCL2A1 and patient survival, data from The Cancer Genome Atlas (TCGA) (serous ovarian cancer) were used for Kaplan–Meier survival analysis (Figure S3).